Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

271

Dawn BiopharmaLatest Jun 17

Vedana Therapeutics · $46M Series A Adcendo · $75M Series C

2rounds

—led

Biotech 2

Series A 1, Series C+ 1

Jun 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Vedana Therapeutics $46M Series A Adcendo $75M Series C

272

European Innovation CouncilLatest Jun 17

Vivici · €12.5M EIC Accelerator blended-finance award Beactica Therapeutics AB · €2.5M Strategic

2rounds

0led

Biotech 1Foodtech 1

Undisclosed 2

Jun 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Undisclosed 2

Vivici €12.5M EIC Accelerator blended-finance award Beactica Therapeutics AB €2.5M Strategic

273

Nexus Venture PartnersLatest Jun 17

Pramaana Labs · $27M Seed Triomics · $22M Series B

2rounds

—led

Enterprise software 1Healthtech 1

Seed 1, Series B 1

Jun 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series B 1

Pramaana Labs $27M Seed Triomics $22M Series B

274

Pangaea VenturesLatest Jun 16

Dioseve · $7M Series A+Kanvas Biosciences · $48M Series A

2rounds

—led

Biotech 2

Series A 2

Jun 16, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Dioseve $7M Series A+Kanvas Biosciences $48M Series A

275

RA CapitalLatest Jun 10

SonoThera · $125M Series B Poplar Therapeutics · $45M Series A+

2rounds

—led

Biotech 2

Series A 1, Series B 1

Jun 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

SonoThera $125M Series B Poplar Therapeutics $45M Series A+

276

FemHealth VenturesLatest Jun 9

GT Medical Technologies · $100M Series E Kanvas Biosciences · $48M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 1, Series C+ 1

Jun 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

GT Medical Technologies $100M Series E Kanvas Biosciences $48M Series A

277

Gilde HealthcareLatest Jun 9

GT Medical Technologies · $100M Series E Adcendo · $75M Series C

2rounds

—led

Biotech 1Healthtech 1

Series C+ 2

Jun 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

GT Medical Technologies $100M Series E Adcendo $75M Series C

278

Viking Global InvestorsLatest Jun 9

GT Medical Technologies · $100M Series E City Therapeutics · $99.5M Series B

2rounds

—led

Biotech 1Healthtech 1

Series B 1, Series C+ 1

Jun 9, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

GT Medical Technologies $100M Series E City Therapeutics $99.5M Series B

279

Connecticut InnovationsLatest Jun 8

Rejuvenate Bio · $6M Strategic P2 Science · $23M Undisclosed

2rounds

—led

Biotech 1Climate tech 1

Undisclosed 2

Jun 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Undisclosed 2

Rejuvenate Bio $6M Strategic P2 Science $23M Undisclosed

280

Kendall Capital PartnersLatest Jun 8

Rejuvenate Bio · $6M Strategic Centivax · $37M Undisclosed

2rounds

—led

Biotech 2

Undisclosed 2

Jun 8, 2026

Details

New companies 2 · Follow-on 0

Stages: Undisclosed 2

Rejuvenate Bio $6M Strategic Centivax $37M Undisclosed

281

Norrsken EvolveLatest Jun 4

New Dawn Bio · €2.1M Pre-Seed Tolemy Bio · €1.4M Pre-Seed

2rounds

—led

Biotech 1Climate tech 1

Pre-seed 2

Jun 4, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 2

New Dawn Bio €2.1M Pre-Seed Tolemy Bio €1.4M Pre-Seed

282

SeedcampLatest Jun 3

Apoha · Undisclosed Series A Outpost Bio · $3.5M Pre-Seed

2rounds

0led

Biotech 1Industrial tech 1

Pre-seed 1, Series A 1

Jun 3, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Series A 1

Apoha Undisclosed Series A Outpost Bio $3.5M Pre-Seed

283

Lumira VenturesLatest Jun 2

Contraline · $92.5M Series B Congruence Therapeutics · $39.5M Series B

2rounds

—led

Biotech 2

Series B 2

Jun 2, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Contraline $92.5M Series B Congruence Therapeutics $39.5M Series B

284

Darwin VenturesLatest May 27

Protuoso Biosciences · $9.5M Seed bitBiome · >$45M Seed+

2rounds

—led

Biotech 2

Seed 2

May 27, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 2

Protuoso Biosciences $9.5M Seed bitBiome >$45M Seed+

285

IQTLatest May 26

bitBiome · >$45M Seed+Science Corporation · $230M Series C

2rounds

—led

Biotech 1Healthtech 1

Seed 1, Series C+ 1

May 26, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

bitBiome >$45M Seed+Science Corporation $230M Series C

286

Valuence VenturesLatest May 26

bitBiome · >$45M Seed+Sift Biosciences · $3.7M Pre-Seed

2rounds

—led

Biotech 2

Pre-seed 1, Seed 1

May 26, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Seed 1

bitBiome >$45M Seed+Sift Biosciences $3.7M Pre-Seed

287

SignalFireLatest May 19

Blank Bio · $7.2M Seed Prudentia Sciences · $20M Series A

2rounds

—led

Biotech 2

Seed 1, Series A 1

May 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Blank Bio $7.2M Seed Prudentia Sciences $20M Series A

288

Hatteras Venture PartnersLatest May 14

CREATE Medicines · $122M Series B Ten63 Therapeutics · $45M Strategic

2rounds

—led

AI 1Biotech 1

Series B 1, Undisclosed 1

May 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

CREATE Medicines $122M Series B Ten63 Therapeutics $45M Strategic

289

Bayern KapitalLatest May 11

NanoStruct · €2.6M Seed Twogee Biotech · €2.2M Seed

2rounds

—led

Biotech 1Climate tech 1

Seed 2

May 11, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 2

NanoStruct €2.6M Seed Twogee Biotech €2.2M Seed

290

ATHOS KGLatest May 6

Kanvas Biosciences · $48M Series A Antheia · $24M Series C second close

2rounds

1led

Biotech 2

Series A 1, Series C+ 1

May 6, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Kanvas Biosciences $48M Series A Antheia $24M Series C second close

291

HBM HealthcareLatest May 6

CellCentric · $220M Series D Parabilis Medicines · $305M Series F

2rounds

—led

Biotech 2

Series C+ 2

May 6, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

CellCentric $220M Series D Parabilis Medicines $305M Series F

292

Ki Tua FundLatest May 6

Kanvas Biosciences · $48M Series A Fermeate · $2M Seed

2rounds

—led

Biotech 2

Seed 1, Series A 1

May 6, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Kanvas Biosciences $48M Series A Fermeate $2M Seed

293

EDBILatest Apr 30

Iterative Health · $77M Series C Cellares · $257M Series D

2rounds

—led

Biotech 1Healthtech 1

Series C+ 2

Apr 30, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

Iterative Health $77M Series C Cellares $257M Series D

294

Decheng CapitalLatest Apr 29

Vivacta Biotechnology · $50M Series A+Syneron Bio · $150M Series B

2rounds

—led

Biotech 2

Series A 1, Series B 1

Apr 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Vivacta Biotechnology $50M Series A+Syneron Bio $150M Series B

295

Hillhouse InvestmentLatest Apr 29

Axoft · $55M Series A Third Arc Bio · $52M Series A+

2rounds

—led

Biotech 1Healthtech 1

Series A 2

Apr 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Axoft $55M Series A Third Arc Bio $52M Series A+

296

Amino CollectiveLatest Apr 22

Calibre · $3.3M Pre-Seed Rivia · $15M Series A

2rounds

—led

Healthtech 2

Pre-seed 1, Series A 1

Apr 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Series A 1

Calibre $3.3M Pre-Seed Rivia $15M Series A

297

Daybreak VenturesLatest Apr 22

Calibre · $3.3M Pre-Seed Barnwell Bio · $6M Seed

2rounds

—led

Biotech 1Healthtech 1

Pre-seed 1, Seed 1

Apr 22, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Seed 1

Calibre $3.3M Pre-Seed Barnwell Bio $6M Seed

298

AgriFoodTech Venture AllianceLatest Apr 20

Planetary · CHF 22M Series A and credit Twogee Biotech · €2.2M Seed

2rounds

0led

Climate tech 1Foodtech 1

Seed 1, Series A 1

Apr 20, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Planetary CHF 22M Series A and credit Twogee Biotech €2.2M Seed

299

Santé VenturesLatest Apr 15

Sonire Therapeutics · $18M Series A beHuman · $4M Seed

2rounds

—led

Healthtech 2

Seed 1, Series A 1

Apr 15, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

Sonire Therapeutics $18M Series A beHuman $4M Seed

300

BoxGroupLatest Apr 14

Helical · $10M Seed Loyal · $100M Series C

2rounds

—led

Biotech 2

Seed 1, Series C+ 1

Apr 14, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series C+ 1

Helical $10M Seed Loyal $100M Series C

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.